Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,315.00
-45.00 (-1.91%)
Last updated: Jun 25, 2025

Yungjin Pharm. Market Cap

Yungjin Pharm. has a market cap or net worth of 404.19 billion as of June 27, 2025. Its market cap has increased by 8.07% in one year.

Market Cap
404.19B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
41.32
Stock Price
2,315.00

Market Cap Chart

Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 404.19B, an increase of 554.00%. That is a compound annual growth rate of 6.00%.

History

DateMarket Cap% Change
Jun 27, 2025404.19B11.17%
Dec 30, 2024363.59B-6.45%
Dec 28, 2023388.65B-34.62%
Dec 29, 2022594.40B-38.56%
Dec 30, 2021967.50B-34.20%
Dec 30, 20201,470.46B21.27%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 71.46T
Celltrion 35.49T
ALTEOGEN 20.84T
Yuhan 7,589.05B
SK Biopharmaceuticals 7,236.14B
HLB Co., Ltd. 6,512.41B
PharmaResearch 4,992.23B
Peptron 4,741.01B
Market Cap Rankings